CRNX
Price
$57.15
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
14 days until earnings call
PTGX
Price
$48.20
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
Ad is loading...

CRNX vs PTGX

Header iconCRNX vs PTGX Comparison
Open Charts CRNX vs PTGXBanner chart's image
Crinetics Pharmaceuticals
Price$57.15
Change-$0.00 (-0.00%)
Volume$545.03K
CapitalizationN/A
Protagonist Therapeutics
Price$48.20
Change-$0.00 (-0.00%)
Volume$356.2K
CapitalizationN/A
View a ticker or compare two or three
CRNX vs PTGX Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CRNX vs. PTGX commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and PTGX is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (CRNX: $57.15 vs. PTGX: $48.20)
Brand notoriety: CRNX and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 72% vs. PTGX: 59%
Market capitalization -- CRNX: $4.09B vs. PTGX: $2.65B
CRNX [@Biotechnology] is valued at $4.09B. PTGX’s [@Biotechnology] market capitalization is $2.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 1 FA rating(s) are green whilePTGX’s FA Score has 2 green FA rating(s).

  • CRNX’s FA Score: 1 green, 4 red.
  • PTGX’s FA Score: 2 green, 3 red.
According to our system of comparison, PTGX is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 6 TA indicator(s) are bullish while PTGX’s TA Score has 4 bullish TA indicator(s).

  • CRNX’s TA Score: 6 bullish, 4 bearish.
  • PTGX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than PTGX.

Price Growth

CRNX (@Biotechnology) experienced а -2.64% price change this week, while PTGX (@Biotechnology) price change was +4.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

CRNX is expected to report earnings on Mar 18, 2025.

PTGX is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($4.09B) has a higher market cap than PTGX($2.65B). PTGX YTD gains are higher at: 110.205 vs. CRNX (60.624). PTGX has higher annual earnings (EBITDA): 156M vs. CRNX (-276.18M). CRNX has more cash in the bank: 863M vs. PTGX (564M). PTGX has less debt than CRNX: PTGX (11M) vs CRNX (53.3M). PTGX has higher revenues than CRNX: PTGX (319M) vs CRNX (1.39M).
CRNXPTGXCRNX / PTGX
Capitalization4.09B2.65B154%
EBITDA-276.18M156M-177%
Gain YTD60.624110.20555%
P/E RatioN/A16.54-
Revenue1.39M319M0%
Total Cash863M564M153%
Total Debt53.3M11M485%
FUNDAMENTALS RATINGS
CRNX vs PTGX: Fundamental Ratings
CRNX
PTGX
OUTLOOK RATING
1..100
2015
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
738
SMR RATING
1..100
9622
PRICE GROWTH RATING
1..100
3836
P/E GROWTH RATING
1..100
10024
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTGX's Valuation (67) in the Biotechnology industry is in the same range as CRNX (90) in the Pharmaceuticals Major industry. This means that PTGX’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (7) in the Pharmaceuticals Major industry is in the same range as PTGX (38) in the Biotechnology industry. This means that CRNX’s stock grew similarly to PTGX’s over the last 12 months.

PTGX's SMR Rating (22) in the Biotechnology industry is significantly better than the same rating for CRNX (96) in the Pharmaceuticals Major industry. This means that PTGX’s stock grew significantly faster than CRNX’s over the last 12 months.

PTGX's Price Growth Rating (36) in the Biotechnology industry is in the same range as CRNX (38) in the Pharmaceuticals Major industry. This means that PTGX’s stock grew similarly to CRNX’s over the last 12 months.

PTGX's P/E Growth Rating (24) in the Biotechnology industry is significantly better than the same rating for CRNX (100) in the Pharmaceuticals Major industry. This means that PTGX’s stock grew significantly faster than CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXPTGX
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 7 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 7 days ago
77%
View a ticker or compare two or three
Ad is loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with ARWR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-1.40%
ARWR - CRNX
46%
Loosely correlated
+0.40%
NTLA - CRNX
45%
Loosely correlated
+2.45%
RARE - CRNX
44%
Loosely correlated
-1.39%
ELVN - CRNX
44%
Loosely correlated
-0.52%
EDIT - CRNX
44%
Loosely correlated
+2.52%
More

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with VIR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
+1.99%
VIR - PTGX
43%
Loosely correlated
+3.61%
BEAM - PTGX
42%
Loosely correlated
+3.71%
CRNX - PTGX
42%
Loosely correlated
-1.40%
RCKT - PTGX
41%
Loosely correlated
+2.64%
RCUS - PTGX
41%
Loosely correlated
+2.08%
More